Document Detail

Real-world outcome from ST elevation myocardial infarction in the very elderly before and after the introduction of a 24/7 primary percutaneous coronary intervention service.
MedLine Citation:
PMID:  20569706     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: It remains unclear whether the superiority of primary percutaneous coronary intervention (PPCI) over thrombolysis for the treatment of ST elevation myocardial infarction (STEMI) extends to the very elderly. Furthermore, the deliverability and efficacy of PPCI in over the 80s has not been investigated in a real-world setting. The aim of this study was to compare outcome from STEMI in patients aged > or =80 before and after the introduction of routine 24/7 PPCI. METHODS: Retrospective observational analysis of all patients aged > or =80 presenting with STEMI to 2 neighboring hospitals in the 3-year period after the introduction of a 24/7 PPCI service and in the preceding 2 years when reperfusion therapy was by thrombolysis. RESULTS: Two hundred fifty-six STEMI patients aged > or =80 were included. After the introduction of PPCI, 84% (136/161) received reperfusion therapy, 73% PPCI, and 12% thrombolysis, compared to 77% ([73/95] 1% PPCI, 76% thrombolysis) previously. Mortality after inception of PPCI was reduced at 12 months (29% vs 41%, P = .04) and 3 years (43% vs 58%, P = .02). Improved outcome was attributable to treatment by PPCI, which was associated with numerically lower 12-month (26% vs 37%, P = .07) and significantly reduced 3-year (42% vs 55%, P = .05) mortality compared to thrombolysis. CONCLUSIONS: Primary PCI can be effectively delivered to very elderly patients presenting with ST elevation MI in a real-world setting and leads to a substantial reduction in mortality compared to patients treated by thrombolysis.
Rhidian J Shelton; Andrew M Crean; Kathryn Somers; Claire Priestley; Carol Hague; Jonathan M Blaxill; Stephen B Wheatcroft; James M McLenachan; John P Greenwood; Daniel J Blackman
Related Documents :
16888266 - Tandem internal carotid artery/middle cerebral artery occlusion: an independent predict...
2973486 - Insights derived from the thrombolysis and angioplasty in myocardial infarction (tami) ...
11811386 - Treatment of cerebrovascular diseases: state of the art and perspectives.
12015866 - New grading system for angiographic evaluation of arterial occlusions and recanalizatio...
17347476 - Trabeculated right ventricular free wall in the chicken heart forms by ventricularizati...
6460896 - Muscle fiber orientation and connective tissue content in the hypertrophied human heart.
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  American heart journal     Volume:  159     ISSN:  1097-6744     ISO Abbreviation:  Am. Heart J.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-23     Completed Date:  2010-07-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  956-63     Citation Subset:  AIM; IM    
Copyright Information:
Copyright 2010 Mosby, Inc. All rights reserved.
Leeds General Infirmary, Leeds, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Angioplasty, Transluminal, Percutaneous Coronary / methods*
Coronary Angiography
Fibrinolytic Agents / therapeutic use*
Follow-Up Studies
Myocardial Infarction / physiopathology,  radiography,  therapy*
Retrospective Studies
Thrombolytic Therapy / methods*
Treatment Outcome
Reg. No./Substance:
0/Fibrinolytic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicent...
Next Document:  Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution ...